NIEMANN-PICK DISEASE DRUG TYPE C TREATMENT MARKET ANALYSIS

Niemann-Pick Disease Drug Type C Treatment Market, by Drug Type (Phase III Drug {Trappsol Cyclo, IB1001}, Marketed Drug {Miglustat (Zavesca)}), by Indication (Niemann-Pick Disease Drug Type C1, Niemann-Pick Disease Drug Type C2), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Dec 2022
Code : CMI4275
Pages :362
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Niemann-Pick Disease Drug Type C Treatment Market – Competitive Landscape

Major players operating in the global niemann-pick disease drug type C treatment market include Johnson & Johnson, Intrabio, Cyclo Therapeutics, Inc., Kempharm, Inc., Azafaros B.V., StrideBio. Sarepta Therapeutics, Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Niemann-Pick Disease Drug Type C Treatment Market to Surpass US$ 222.33 Mn by 2030

Credibility and Certifications

9001:2015

27001:2022

NIEMANN-PICK DISEASE DRUG TYPE C TREATMENT MARKET ANALYSIS

Leading Companies

Niemann-Pick Disease Drug Type C Treatment Market Report Snapshots

EXISTING CLIENTELE